Circulating tumor DNA in hepatocellular carcinoma: trends and challenges

被引：0
作者：
Jia-Cheng Tang
Yi-Li Feng
Tao Guo
An-Yong Xie
Xiu-Jun Cai
机构：
[1] Zhejiang University,Zhejiang Province Key Laboratory of Laparoscopic Technology, Sir Run Run Shaw Hospital
[2] Zhejiang University,Institute of Translational Medicine
来源：
Cell & Bioscience | / 6卷
关键词：
Cell free DNA; Circulating tumor DNA; Biomarker; Liquid biopsy; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Molecular characterization of individual patients’ tumor cells is becoming increasingly important in offering effective treatment for patients in clinical practice. Recent advances in the field have indicated that circulating tumor DNA (ctDNA) has huge potential to serve as a biomarker for early detection and precision treatment as well as prognosis of hepatocellular carcinoma (HCC). As ctDNA in HCC patients harbors the molecular characteristics of HCC tumor cells, ctDNA analysis in the blood may be sufficient for convenient, non-invasive and accurate detection, providing information for HCC diagnosis, treatment and prognosis. In this review, we will summarize and discuss current trends and challenges of ctDNA application in HCC.
引用
收藏
相关论文
共 50 条
[31]   Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study [J].
Pommergaard, H. C. ;
Yde, C. W. ;
Ahlborn, L. B. ;
Andersen, C. L. ;
Henriksen, T., V ;
Hasselby, J. P. ;
Rostved, A. A. ;
Sorensen, C. L. ;
Rohrberg, K. S. ;
Nielsen, F. C. ;
Rasmussen, A. .
MOLECULAR BIOLOGY REPORTS, 2022, 49 (02) :1609-1616
[32]   Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study [J].
H. C. Pommergaard ;
C. W. Yde ;
L. B. Ahlborn ;
C. L. Andersen ;
T. V. Henriksen ;
J. P. Hasselby ;
A. A. Rostved ;
C. L. Sørensen ;
K. S. Rohrberg ;
F. C. Nielsen ;
A. Rasmussen .
Molecular Biology Reports, 2022, 49 :1609-1616
[33]   Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges [J].
Xue, Yuhang ;
Xia, Xuejiao ;
Liu, Xin ;
Zheng, Yanhua ;
Gu, Hongcang ;
Wang, Xiaoxue .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (02)
[34]   Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma [J].
Buedeyri, Ibrahim ;
Guckelberger, Olaf ;
Oppermann, Elsie ;
Roy, Dhruvajyoti ;
Sliwinski, Svenja ;
Becker, Felix ;
Struecker, Benjamin ;
Vogl, Thomas J. ;
Pascher, Andreas ;
Bechstein, Wolf O. ;
Lorentzen, Anna ;
Heikenwalder, Mathias ;
Juratli, Mazen A. .
CELLS, 2025, 14 (01)
[35]   Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma [J].
Salehi, Mahsa ;
Lavasani, Zohre Miri ;
Alikhani, Hani Keshavarz ;
Shokouhian, Bahare ;
Hassan, Moustapha ;
Najimi, Mustapha ;
Vosough, Massoud .
CELLS, 2023, 12 (18)
[36]   Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma [J].
Wang, Jian ;
Huang, Ao ;
Wang, Yu-Peng ;
Yin, Yue ;
Fu, Pei-Yao ;
Zhang, Xin ;
Zhou, Jian .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
[37]   Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges [J].
Lu, Li-Chun ;
Hsu, Chih-Hung ;
Hsu, Chiun ;
Cheng, Ann-Lii .
LIVER CANCER, 2016, 5 (02) :128-138
[38]   Clinical applications of circulating tumor cells in hepatocellular carcinoma [J].
Hua, Yinggang ;
Dong, Jingqing ;
Hong, Jinsong ;
Wang, Bailin ;
Yan, Yong ;
Li, Zhiming .
FRONTIERS IN ONCOLOGY, 2022, 12
[39]   Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study [J].
Zhu, Gui-Qi ;
Liu, Wei-Ren ;
Tang, Zheng ;
Qu, Wei-Feng ;
Fang, Yuan ;
Jiang, Xi-Fei ;
Song, Shu-Shu ;
Wang, Han ;
Tao, Chen-Yang ;
Zhou, Pei-Yun ;
Huang, Run ;
Gao, Jun ;
Sun, Hai-Xiang ;
Ding, Zhen-Bin ;
Peng, Yuan-Fei ;
Dai, Zhi ;
Zhou, Jian ;
Fan, Jia ;
Shi, Ying-Hong .
MOLECULAR ONCOLOGY, 2022, 16 (02) :549-561
[40]   Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas [J].
Sameer A. Dhayat ;
Zixuan Yang .
Journal of Cancer Research and Clinical Oncology, 2020, 146 :1625-1645
12345